Independent Director · INOVIO PHARMACEUTICALS, INC. (INO)

Chair, Audit Committee

Lota S. Zoth — INOVIO PHARMACEUTICALS Director Compensation (2025)

Fiscal year 2025 director compensation for Lota S. Zoth at INOVIO PHARMACEUTICALS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 7, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

INOVIO PHARMACEUTICALS Director Compensation Table · the one fiscal year held
In US dollars, as INOVIO PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$77,500$0$0—$77,500

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: INOVIO PHARMACEUTICALS, INC. DEF 14A filed April 7, 2026, accession 0001055726-26-000011, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

INOVIO PHARMACEUTICALS pays directors a $45,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit (Chair)

The rest of the INOVIO PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Ann C. MillerIndependent Director$91,750
David B. WeinerIndependent Director$52,500
Jacqueline E. SheaDirector$0
Jay P. ShepardIndependent Director$80,000
Roger D. DanseyIndependent Director$72,095
Simon X. BenitoChair of the Board$117,500
Wendy L. YarnoIndependent Director$82,500

The full INOVIO PHARMACEUTICALS compensation record

free company brief

This page is one director within INOVIO PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy